Effective Dose of Ramosetron for Prophylaxis of Postoperative Nausea and Vomiting in High-Risk Patients

Table 2

Patient characteristics.

	Group A; (N = 16)	Group B; (N = 16)	Group C; (N = 15)
Age (years)	60.6 ± 10.5	57.0 ± 11.3	60.9 ± 17.6
Sex (male : female)	5 : 11	3 : 13	4 : 11
Height (cm)	161.3 ± 6.5	156.6 ± 7.0	159.9 ± 6.5
Weight (kg)	59.9 ± 8.7	55.4 ± 8.4	63.7 ± 9.7
ASA PS status	1.56 ± 0.51	1.63 ± 0.5	1.73 ± 0.5
Apfel’s PONV risk [1]	3.31 ± 0.95	3.38 ± 0.81	3.00 ± 0.85

The values are shown as means ± SD or numbers of patients.
ASA PS: American Society of Anesthesiology Physical Status.
PONV: Postoperative nausea and vomiting.